worldwid
epidem
sever
acut
respiratori
syndrom
sar
caus
novel
coronaviru
call
sarscov
report
use
dnazym
catalyt
dna
target
untransl
region
utr
highli
conserv
fragment
sar
genom
approach
suppress
sarscov
replic
monodna
enzym
possess
catalyt
motif
synthes
test
vitro
cell
cultur
materi
method
sarscov
total
rna
isol
extract
sarscovwhu
strain
convert
cdna
design
rnacleav
dnazym
target
loop
region
utr
sarscov
design
dnazym
mutant
version
mut
control
consist
arm
sequenc
catalyt
core
vitro
cleavag
perform
use
vitro
transcrib
utr
rna
substrat
vector
contain
fuse
utr
enhanc
green
fluoresc
protein
egfp
cotransfect
dnazym
cell
cell
express
egfp
visual
fluoresc
microscopi
analyz
fluorescenceactiv
cell
sort
fac
result
demonstr
dnazym
could
effici
cleav
sarscov
rna
substrat
vitro
inhibit
express
sarscov
utregfp
fusion
rna
mammalian
cell
work
present
model
system
rapidli
screen
effect
dnazym
target
sar
provid
basi
potenti
therapeut
use
dna
enzym
combat
sar
infect
sever
acut
respiratori
syndrom
sar
lifethreaten
form
pneumonia
cours
month
total
probabl
case
highli
infecti
diseas
report
august
includ
death
diseas
etiolog
link
novel
coronaviru
name
sarsassoci
coronaviru
sarscov
genom
sequenc
sarscov
isol
obtain
number
index
patient
publish
provid
import
inform
phylogeni
variabl
viral
genom
characterist
linear
posit
singlestrand
rna
viru
kb
length
contain
identifi
open
read
frame
orf
short
untransl
region
termini
current
approv
antivir
drug
highli
effect
coronavirus
strategi
exemplifi
use
antisens
rna
deoxyoligonucleotid
report
inhibit
gene
express
interf
rna
transcript
translat
unfortun
administr
larg
amount
antisens
phosphorothio
oligonucleotid
led
toxic
problem
recent
sever
rnacleav
dnazym
shown
activ
cleav
substrat
rna
simul
physiolog
condit
two
repres
catalyt
motif
figur
report
santoro
joyc
vitro
select
combinatori
librari
dna
sequenc
effici
dnazym
term
consist
conserv
catalyt
core
nucleotid
flank
two
variabl
hybrid
arm
theoret
design
complementari
target
rna
cleav
unpair
purin
pair
pyrimidin
residu
endow
tremend
potenti
applic
downregul
target
gene
date
number
group
explor
potenti
dnazym
biolog
system
banerjea
cowork
attempt
inhibit
gene
express
dnazym
target
tar
gag
tatrev
rna
coreceptor
sun
cowork
target
viral
sequenc
gene
cmyc
gene
smooth
muscl
cell
dnazym
biolog
activ
dnazym
cleav
rna
deriv
bcrabl
huntingtin
env
gene
hiv
mrna
influenza
viru
also
examin
report
work
demonstr
dnazym
use
potenti
tool
specif
inhibit
diseaserel
gene
studi
explor
potenti
use
dnazym
target
sar
utr
fuse
green
fluoresc
protein
gfp
gene
dnazym
design
purpos
found
effect
vitro
vivo
suggest
dnazym
could
new
class
antisar
agent
african
green
monkey
kidney
vero
cell
grown
maintain
dulbecco
modifi
eagl
medium
dmem
supplement
heatinactiv
fetal
bovin
serum
fb
gibco
invitrogen
corpor
c
sarscovwhu
strain
access
maintain
propag
vero
cell
describ
sarscov
total
rna
isol
extract
sarscovwhu
strain
rna
convert
cdna
revers
transcript
follow
primer
use
amplifi
bp
fragment
utr
sar
genom
polymeras
chain
reaction
pcr
ecori
digest
site
underlin
aggatcc
bamhi
digest
site
underlin
condit
pcr
c
min
c
c
c
min
cycl
follow
c
min
amplifi
product
analyz
electrophoresi
clone
pcr
clone
vector
subclon
multipl
clone
site
mc
vector
bd
bioscienc
clonetech
transform
escherichia
coli
strain
sequenc
integr
construct
verifi
restrict
map
dna
sequenc
base
santoro
joyc
report
design
rnacleav
dnazym
possess
motif
target
site
select
loop
region
predict
secondari
structur
utr
design
dnazym
consist
arm
sequenc
catalyt
core
synthes
use
standard
chemistri
sangon
shanghai
china
detail
target
sequenc
dnazym
mutant
control
mt
shown
figur
indic
nucleotid
target
gene
left
unpair
cleavag
expect
take
place
mutant
dna
enzym
mt
possess
singl
mutat
catalyt
motif
g
c
gener
substrat
rna
test
dnazym
cleavag
activ
vitro
sarscov
utr
produc
pcr
recombin
plasmid
utregfp
forward
primer
contain
promot
sequenc
ctgtaatacgactcactatagggccaagtacgccccctattga
revers
primer
gtagttgccgtcgtccttga
amplifi
fragment
bp
length
predict
cleavag
site
utr
sar
midpoint
fragment
condit
pcr
c
min
c
c
c
min
cycl
follow
c
min
amplifi
product
analyz
electrophoresi
recov
agaros
gel
purifi
dna
templat
use
vitro
transcript
transcript
kit
jingmei
biotech
beij
china
volum
recommend
manufactur
incub
h
c
upon
complet
transcript
dna
templat
remov
digest
dnase
u
templat
dna
takara
biotechnolog
dalian
china
min
c
transcript
rna
purifi
tesatur
phenolchloroform
chloroformisoamyl
alcohol
cleavag
reaction
purifi
substrat
rna
nm
dnazym
variou
concentr
mix
mm
trishcl
ph
presenc
mm
mgcl
u
rnasin
prevent
nonspecif
rna
degrad
prior
mix
enzym
target
rna
solut
denatur
separ
min
c
cleavag
reaction
incub
c
singl
turnov
kinet
experi
excess
dnazym
use
cleavag
reaction
nm
multipl
kinet
reaction
concentr
dnazym
nm
employ
aliquot
taken
defin
interv
first
reaction
reaction
stop
ad
mm
edta
cool
ice
sampl
buffer
formaldehyd
buffer
formamid
ad
cleavag
reaction
prior
load
onto
agaros
gel
gel
stain
ethidium
bromid
intens
quantifi
quantiti
one
softwar
gene
snap
data
analyz
fit
either
linearli
obtain
initi
veloc
v
init
substrat
excess
experi
singl
exponenti
decay
function
obtain
observ
cleavag
rate
enzym
excess
experi
use
origin
microc
softwar
northampton
usa
valu
given
mean
standard
deviat
sd
least
three
independ
experi
vero
cell
grown
confluenc
plate
cotransfect
fix
amount
utregfp
along
vari
amount
dna
enzym
respect
h
use
lipofectamin
plu
invitrogen
usa
final
volum
h
incub
presenc
lipofectamin
plu
cell
wash
dmem
without
serum
incub
h
medium
fb
cell
express
egfp
visual
fluoresc
microscopi
nikon
tokyo
japan
transfect
cell
trypsin
collect
centrifug
cell
rins
phosphatebuff
salin
pb
resuspend
polyformaldehyd
kept
c
pb
ad
sampl
cell
analyz
beckman
coulter
counter
percentag
cell
express
gfp
h
posttransfect
cell
collect
total
rna
extract
use
trizol
accord
manufactur
instruct
realtim
pcr
reaction
carri
icycl
iq
biorad
primer
use
pcr
caagctgacc
ctgaagttca
gave
rise
bp
product
gfp
gene
standard
curv
gener
use
serial
dilut
utregfp
copi
amplif
condit
room
temperatur
rt
c
min
c
min
c
c
c
mean
ct
valu
collect
use
analysi
target
site
select
dnazym
design
sarscov
belong
coronaviru
famili
structur
similar
coronavirus
contain
e
n
gene
product
viru
featur
discontinu
transcript
subgenom
mrna
regul
pretranscrib
leader
sequenc
specif
trss
utr
genom
utr
sequenc
contribut
regul
viru
gene
express
strikingli
high
degre
sequenc
conserv
utr
region
among
sarscov
strain
identifi
thu
far
suggest
function
import
region
target
utr
would
therefor
present
feasibl
strategi
also
potenti
avoid
possibl
emerg
escap
mutant
virus
dnazym
design
cleavag
site
nucleotid
arm
length
chosen
format
previous
report
gave
rise
much
effici
catalyt
activ
base
balanc
hybrid
strength
g
kinet
turnov
cleavag
site
select
au
dinucleotid
sinc
hierarchi
ry
reactiv
r
purin
pyrimidin
dnazym
follow
gener
scheme
au
gu
gc
ac
test
cleavag
activ
conduct
vitro
cleavag
analys
use
kb
rna
transcript
transcrib
primerbas
pcr
fragment
utr
cleavag
point
middl
transcript
thu
two
band
cleavag
product
would
appear
posit
gel
singl
turnov
assay
access
use
substrat
rna
effici
cleav
expect
size
cleavag
product
figur
observ
rate
min
figur
multipl
turnov
condit
substrat
cleav
initi
veloc
nm
min
figur
mutant
dnazym
mt
subject
cleavag
assay
condit
show
cleavag
figur
lower
panel
result
demonstr
design
dnazym
chemic
activ
cleav
substrat
rna
capac
turnov
vitro
condit
also
suggest
local
rna
structur
target
access
simul
physiolog
condit
examin
efficaci
design
dnazym
crucial
sensit
meaning
system
perform
assay
chose
use
fusion
transcript
utr
gfp
gene
model
system
system
dnazym
target
link
end
gfp
gene
provid
versatil
assay
monitor
dnazym
activ
cell
figur
dnazym
cleavag
occur
anticip
truncat
fusion
rna
would
subject
nucleas
degrad
therefor
level
gfp
express
would
reduc
could
monitor
fluoresc
microscopi
utregfp
construct
transfect
vero
cell
express
egfp
gene
could
easili
observ
appear
slightli
weaker
parent
vector
figur
minor
chang
could
due
effect
extra
utr
sequenc
promot
activ
transcript
effici
gfp
gene
howev
system
sensit
enough
use
assay
dnazym
activ
effect
cleavag
utregfp
fusion
rna
egfp
express
vero
cell
advantag
use
gfp
facil
direct
observ
target
gene
express
fluoresc
microscopi
demonstr
design
dnazym
could
target
mrna
sar
utr
suppress
egfp
express
cotransfect
vero
cell
utregfp
differ
ratio
data
show
cotransfect
compar
mt
control
significantli
decreas
fluoresc
level
effect
gfp
cell
cotransfect
contain
utr
sequenc
figur
effect
egfp
express
shown
dosedepend
transfect
procedur
effect
cell
growth
data
shown
confirm
dnazym
effect
gfp
express
percentag
gfpexpress
cell
measur
use
flow
cytometri
result
show
dosedepend
reduct
number
gfp
cell
transfect
utregfp
tabl
reduct
seen
cell
transfect
either
parent
vector
mutant
dnazym
mut
determin
effect
gfp
express
due
cleavag
utrgfp
mrna
realtim
pcr
perform
measur
level
target
rna
shown
treatment
utregfptransfect
cell
led
mark
reduct
target
mrna
level
evidenc
tabl
demonstr
dnazym
elicit
degrad
utregfp
mrna
sequenc
sequencespecif
manner
result
suppress
egfp
gene
express
present
studi
dnazym
cotransfect
target
vector
vero
cell
although
cotransfect
fulli
mimic
cell
infect
viru
show
dnazym
could
enter
cell
find
target
rna
previou
studi
show
dnazym
transfect
mammalian
cell
remain
stabl
biolog
activ
h
support
result
suffici
dnazym
transfect
cell
function
targetspecif
gene
suppressor
taken
togeth
studi
show
dnazym
effici
cleav
utr
sarscov
vitro
cell
impli
utr
may
well
good
target
molecular
target
studi
also
present
conveni
system
screen
nucleicacidbas
agent
inhibit
sar
replic
sinc
dnazym
inher
physicochem
advantag
nucleicacidbas
agent
higher
target
flexibl
minim
chemic
modif
rel
resist
nucleas
degrad
low
cost
synthesi
may
clinic
appeal
new
class
antisar
agent
